Kushner Joshua's Form 4 filing
Oscar Health, Inc. (OSCR) · filed Sep 18, 2026
- Accession no.
- 0001193125-26-395853
- Filed
- Sep 18, 2026, 8:27 PM ET
- Trade date
- Sep 18, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 5 derivative transactions. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kushner JoshuaCIK 0001844181 | Director, Officer (Co-Founder and Vice Chairman), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Class A Common Stock | JOtherDisposed | −6,268,097 | $0.00F1 | $0 | 0 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherDisposed | −75,520 | $0.00F1 | $0 | 0 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherAcquired | +1,323,589 | $0.00F1 | $0 | 1,323,589 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherAcquired | +4,855,810 | $0.00F1 | $0 | 4,855,810 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherAcquired | +164,218 | $0.00F1 | $0 | 164,218 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherDisposed | −1,323,589 | $0.00F4 | $0 | 0 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherDisposed | −4,855,810 | $0.00F4 | $0 | 0 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherDisposed | −164,218 | $0.00F4 | $0 | 0 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Class A Common Stock | JOtherDisposed | −1,323,589 | $0.00F1 | $0 | 4,779,730 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherDisposed | −4,855,810 | $0.00F1 | $0 | 17,535,258 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherDisposed | −164,218 | $0.00F1 | $0 | 593,021 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherAcquired | +6,268,097 | $0.00F1 | $0 | 6,268,097 | Indirect | Duplicate filing |
| Sep 18, 2026 | Class A Common Stock | JOtherAcquired | +75,520 | $0.00F1 | $0 | 75,520 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On September 18, 2026, (i) Thrive Capital Partners II, L.P. ("Thrive II") transferred 1,307,831 and 15,758 shares of Class B Common Stock to Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth") and Claremount VII Associates, L.P. ("Claremount VII"), respectively, in exchange for 1,307,831 and 15,758 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively; (ii) Thrive Capital Partners III, L.P. ("Thrive III") transferred 4,798,003 and 57,807 shares of Class B Common Stock to Thrive VII Growth and Claremount VII, respectively, in exchange for 4,798,003 and 57,807 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively; (iii) Claremount TW, L.P. ("Claremount TW") transferred 162,263 and 1,955 shares of Class B Common Stock to Thrive VII Growth and Claremount VII, respectively, in exchange for 162,263 and 1,955 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively.
Referenced by the price of 5 transactions in Table I and 5 transactions in Table II.
- F4
On September 18, 2026, (i) Thrive II distributed to its limited partners and sole general partner, pro rata and without consideration, 1,323,589 shares of Class A Common Stock; (ii) Thrive III distributed to its limited partners and sole general partner, pro rata and without consideration, 4,855,810 shares of Class A Common Stock; and (iii) Claremount TW distributed to its limited partners and sole general partner, pro rata and without consideration, 164,218 shares of Class A Common Stock. Each of Thrive Partners II GP, LLC and Thrive Partners III GP, LLC, in turn, distributed to their members, pro rata and without consideration, the shares of Class A Common Stock received in the foregoing distributions. Such distributions were made in accordance with the exemptions afforded by Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
Referenced by the price of 3 transactions in Table I.